Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 6.9B | 7.1B | 6.3B | 6.0B |
Cost of revenue | 3.9B | 3.9B | 3.5B | 3.3B |
Gross profit | 3.0B | 3.2B | 2.7B | 2.7B |
Operating expense | ||||
Research & development | 67M | 82M | 51M | 56M |
Selling general and admin | 1.7B | 1.8B | 1.6B | 1.6B |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.4B | 1.1B | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 1.3B | 1.0B | 941M |
Tax provision | 289M | 282M | 263M | 240M |
Net income | 844M | 978M | 757M | 701M |
Basic EPS | 1.8 | 2.1 | 1.6 | 1.5 |
Diluted EPS | 1.8 | 2.1 | 1.6 | 1.5 |
Basic average shares | 453.3M | 454.5M | 453.0M | 453.3M |
Diluted average shares | 453.3M | 454.5M | 453.0M | 453.3M |
EBITDA | 1.7B | 1.4B | 1.2B | 1.4B |
Net income from continuing op. | 1.2B | 1.4B | 1.1B | 1.0B |
Minority interests | -9M | -9M | -14M | -11M |
Preferred stock dividends | 0 | 0 | 0 | 0 |